MicrobiologybioRxiv
Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy
DOI 10.1128/aac.00481-23
Author
Y. S. Chang
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2018-2023 · peak 1/yrCo-Author Collaboration Network
10 top collaborators · 22 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship4 papers
Recent·Most cited
- Pharmacology & ToxicologybioRxiv
Preserved efficacy and reduced toxicity with intermittent linezolid dosing in combination with bedaquiline and pretomanid in a murine TB model
DOI 10.1128/aac.01178-20 - MicrobiologybioRxiv
Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis
V. Saini, N. C. Ammerman, Y. S. Chang…·J. H. Grosset
This study tests a new TB treatment regimen combining high-dose rifapentine and clofazimine in mouse models, finding it more effective than either drug alone in shortening treatment duration.
DOI 10.1128/aac.00388-19 - MicrobiologybioRxiv
Developing a newborn rat model of meningitis without concomitant bacteremia by intraventricular injection of K1 (-) Escherichia coli
W. S. Park, S. Y. AHN, Y. S. Chang…·S. Y. JOO
This study develops a newborn rat model of meningitis without systemic bacteremia using intraventricular injection of K1-negative E. coli, showing dose-dependent survival and brain injury.
DOI 10.1111/ped.14108